STOKE THERAPEUTICS INC (STOK) Stock Income Statement
NASDAQ:STOK - Nasdaq - US86150R1077 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 190.91M | 36.55M | 8.78M | 12.41M | 0.00 | |||
| Operating Expenses | 152.67M | 137.93M | 123.55M | 116.76M | 86.07M | |||
| Research and Development | 99.44M | 89.13M | 82.23M | 77.84M | 54.17M | |||
| Selling, General, and Administrative Expenses | 53.23M | 48.79M | 41.32M | 38.92M | 31.90M | |||
| Operating Income | 38.24M | -101.37M | -114.77M | -104.36M | -86.07M | |||
| Interest Income/Expense | 13.10M | 12.64M | 9.91M | 3.12M | 120.00K | |||
| Other Income/Expense | 209.00K | -247.00K | 166.00K | 170.00K | 140.00K | |||
| Income Before Taxes | 51.55M | -88.98M | -104.70M | -101.07M | -85.81M | |||
| Net Income | 50.27M | -88.98M | -104.70M | -101.07M | -85.81M | |||
| EBITDA | 40.33M | -99.19M | -112.30M | -102.81M | -85.10M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 0.79 | -1.65 | -2.38 | -2.60 | -2.34 | |||
| Non GAAP EPS | 0.87 | -1.68 | -2.37 | -2.60 | -2.33 | |||
| Statistics | ||||||||
| Profit Margin | 26.33% | -243.42% | -1192.47% | -814.42% | N/A | |||
| Operating Profit Margin | 20.03% | -277.31% | -1307.21% | -840.93% | N/A | |||
All data in USD